Nearly all Americans say prenatal heart disease screening is important for women
Core finding
In a Verasight survey of 1,000 U.S. adults conducted Nov. 14 to 20, 2025, 95% of Americans said it is at least somewhat important to assess all women for risk of developing heart disease as part of their routine prenatal care, regardless of symptoms or medical history. This includes 56% who said very important, 27% who said important, and 12% who said somewhat important.
Few Americans said this screening is not at all important (1%). Another 4% said they are not sure.
Topline scale
95% of Americans say prenatal heart disease screening is important for women.
How important is it to assess all women for risk of developing heart disease as part of their routine prenatal care, regardless of symptoms or medical history?
n = 1,000 · Nov 14–20, 2025 · MoE ±3.2%
Methodology
Full methodology →| Mode | Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting |
|---|---|
| Population | US adults age 18+ |
| Field dates | Nov 14–20, 2025 |
| Base (unweighted) | 1,000 |
| Margin of error | ±3.2% |
| Module | Module 1 |
| Sponsor | Verasight |
| Weight variable | weight |
| Weighting targets | age, race/ethnicity, sex, income, education, region, metropolitan status |
Sources
- reports.verasight.io/r/verasight-apha-2025
How important is it to assess all women for risk of developing heart disease as part of their routine prenatal care, regardless of symptoms or medical history?
Cite this question
Verasight APHA Omnibus Survey #2025-148, fielded November 14-20, 2025, N=1,000 US adults age 18+, +/- 3.2%.